secwatch.observer — SEC 8-K summary
======================================

Issuer:     DiaMedica Therapeutics Inc. (DMAC)
CIK:        0001401040
Form:       8-K/A
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001437749-23-006083
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

DiaMedica appoints Tanya N. Lewis to Board and Compensation Committee
---------------------------------------------------------------------

- Tanya N. Lewis appointed to DiaMedica Board effective March 1, 2023.
- Lewis appointed to Compensation Committee effective March 9, 2023.
- 8-K/A filed to disclose committee membership previously undetermined.
- No other changes from initial Form 8-K filed March 6, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/0001437749-23-006083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/dmtp20230309_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-006083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer